| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.22 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |